P

Recent Diabetes CVD Trials on SGLT2 and GLP1 and their Effects on Body Weight and Hypertension

By Peter Nilsson
5 views
September 16, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

10:56
Novartis Cardiology

Expert Insights on Pivotal Phase 3 and Long-term Trial Data in Prima…

Feat. D. G. Karalis, M. Myerson

Featured Video

13:03
Novartis Cardiology

Expert Insights on Adding a Non-Statin Lipid-Lowering Therapy in a R…

Feat. M. Koren

Related Content

AUTOPLAY
06:38
Allan Jaffe

What Does Elevated Troponin Mean in COVID-19?

16:57
William White

Ambulatory Blood Pressure Monitoring

64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

Primer on Diabetes Management

Feat. S. Inzucchi
20:48
Michael Gallagher

Cardiac CT in 2023: From Anatomy to Physiology to Plaque Burden and …

26:57
Houston Methodist

Endoscopic Weight Loss Therapies - A Paradigm Shift in the Treatment…

Feat. T. R. Mccarty
10:12
AHA 2022 Conference Coverage

AHA 2022: Chlorthalidone Compared to Hydrochlorothiazide for the Pre…

Feat. A. Ishani
11:37
ACC 2022 Conference Coverage

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

Feat. P. Heidenreich
49:21
Physicians Committee for Responsible Medicine

Health of Vegetarians and Vegans: Findings From EPIC-Oxford and Othe…

Feat. T. J. Key
28:13
National Lipid Association

New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty…

Feat. R. Mason
11:25
ACC 2023 Conference Coverage

ACC 2023: SGLT2i Use - Dos and Don'ts

Feat. A. Armbruster
27:14
MUSC Cardiology

Which Diuretic(s) Are Best in HF? Update Based on Recent Clinical Tr…

Feat. R. Mentz
18:43
ASPC 2019 Congress on CVD Prevention

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

Feat. R. DeFronzo
15:40
ACC 2022 Conference Coverage

ACC 2022: Triple Therapy - When to Use and How Long

Feat. D. Kumbhani
15:06
Robert Busch

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

12:26
Juan Frias

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

26:01
Cardiology Fiesta 2017

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Feat. R. DeFronzo
21:33
AdventHealth

FLOW: The First Dedicated CKD Outcomes Trial With a GLP-1 Receptor A…

Feat. R. Pratley
14:22
Scripps Health

Panel Discussion: Hypertension Management and Coronary Calcium Scori…

Feat. D. Cork, C. Mende, A. Robinson
45:45
Houston Methodist DeBakey Heart and Vascular Center

Directions of Cardiology in the Next Decade: 2022-2032

Feat. E. Braunwald
17:44
Rita Jermyn

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease